Frédérique Claudot
Research Subjects
Frédérique Claudot has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
Henry Coudane
4 shared publications- François Alla
Division of Public Health, Prevention Department, University Hospital Center, Bordeaux, France
3 shared publications - Antoine Baumann
Ctr Hosp Univ Nancy, Hop Cent, Dept Anesthesie Reanimat, Nancy, France
2 shared publications - Gerard Audibert
Service d'anesthésie-réanimation, hôpital Central, CHU de Nancy, 29, avenue du Maréchal-de-Lattre-de-Tassigny, 54000 Nancy, France
2 shared publications - Louis Puybasset
Department of Anesthesiology and Critical Care Medicine, Sorbonne Université, AP-HP, Pitié-Salpêtrière Hospital, 75006 Paris, France
2 shared publications - Paul-Michel Mertes
Département d'Anesthésie-réanimation, CHU de Nancy, Hôpital Central, 29 Avenue de Lattre de Tassigny, 54035 Nancy Cedex, France
2 shared publications
Latest Publications
- 1 October 2012
- Published by Elsevier in La Presse Médicale
- Vol. 41 (10) , e530-e538
Réanimation non thérapeutique en fin de vie pour préservation des organes en vue d’un don : problèmes éthiques et légaux
- 1 October 2012
- Published by Elsevier in La Presse Médicale
- Vol. 41 (10) , e530-e538
Réanimation non thérapeutique en fin de vie pour préservation des organes en vue d’un don : problèmes éthiques et légaux
- Open Access
- 1 January 2011
- Published by Springer Nature in Philosophy, Ethics, and Humanities in Medicine
- Vol. 6 (1) , 4
The ethical and legal aspects of palliative sedation in severely brain-injured patients: a French perspective
To fulfill their crucial duty of relieving suffering in their patients, physicians may have to administer palliative sedation when they implement treatment-limitation decisions such as the withdrawal of life-supporting interventions in patients with poor prognosis chronic severe brain injury. The issue of palliative sedation deserves particular attention in adults with serious brain injuries and in neonates with severe and irreversible brain lesions, who are unable to express pain or to state their wishes. In France, treatment limitation decisions for these patients are left to the physicians. Treatment-limitation decisions are made collegially, based on the presence of irreversible brain lesions responsible for chronic severe disorders of consciousness. Before these decisions are implemented, they are communicated to the relatives. Because the presence and severity of pain cannot be assessed in these patients, palliative analgesia and/or sedation should be administered. However, palliative sedation is a complex strategy that requires safeguards to prevent a drift toward hastening death or performing covert euthanasia. In addition to the law on patients' rights at the end of life passed in France on April 22, 2005, a recent revision of Article 37 of the French code of medical ethics both acknowledges that treatment-limitation decisions and palliative sedation may be required in patients with severe brain injuries and provides legal and ethical safeguards against a shift towards euthanasia. This legislation may hold value as a model for other countries where euthanasia is illegal and for countries such as Belgium and Netherlands where euthanasia is legal but not allowed in patients incapable of asking for euthanasia but in whom a treatment limitation decision has been made.
- 1 January 2011
- Published by Springer Nature in Philosophy, Ethics, and Humanities in Medicine
- Vol. 6 (1) , 4
Open AccessThe ethical and legal aspects of palliative sedation in severely brain-injured patients: a French perspective
To fulfill their crucial duty of relieving suffering in their patients, physicians may have to administer palliative sedation when they implement treatment-limitation decisions such as the withdrawal of life-supporting interventions in patients with poor prognosis chronic severe brain injury. The issue of palliative sedation deserves particular attention in adults with serious brain injuries and in neonates with severe and irreversible brain lesions, who are unable to express pain or to state their wishes. In France, treatment limitation decisions for these patients are left to the physicians. Treatment-limitation decisions are made collegially, based on the presence of irreversible brain lesions responsible for chronic severe disorders of consciousness. Before these decisions are implemented, they are communicated to the relatives. Because the presence and severity of pain cannot be assessed in these patients, palliative analgesia and/or sedation should be administered. However, palliative sedation is a complex strategy that requires safeguards to prevent a drift toward hastening death or performing covert euthanasia. In addition to the law on patients' rights at the end of life passed in France on April 22, 2005, a recent revision of Article 37 of the French code of medical ethics both acknowledges that treatment-limitation decisions and palliative sedation may be required in patients with severe brain injuries and provides legal and ethical safeguards against a shift towards euthanasia. This legislation may hold value as a model for other countries where euthanasia is illegal and for countries such as Belgium and Netherlands where euthanasia is legal but not allowed in patients incapable of asking for euthanasia but in whom a treatment limitation decision has been made.
- 1 November 2010
- Published by Elsevier in Archives of Cardiovascular Diseases
- Vol. 103 (11-12) , 595-602
Analysis of patient claims related to care in a university cardiology department over the period 2003–2007
- 1 November 2010
- Published by Elsevier in Archives of Cardiovascular Diseases
- Vol. 103 (11-12) , 595-602
Analysis of patient claims related to care in a university cardiology department over the period 2003–2007
- Open Access
- 1 January 2009
- Published by Springer Nature in Critical Care
- Vol. 13 (1) , 204
Ethics review: End of life legislation – the French model
French law 2005-370 of April 22, 2005 (Leonetti's law) brings new rights to patients and clarifies medical practices regarding end of life care. This new law prohibits unreasonable obstinacy in investigations or therapeutics and authorizes the withholding or withdrawal of treatments when they appear "useless, disproportionate or having no other effect than solely the artificial preservation of life". Relief from pain is a fundamental right of patients. With regard to pain control, the law also allows doctors to dispense to patients "in an advanced or final phase of a serious and incurable affliction" anti-pain treatments as needed, even if these treatments, as a side effect, hasten their death. The drafting of advance directives regarding end of life constitutes a new right of patients. The decision to withdraw or withhold a treatment from a patient unable to express their will has to take into account the wishes they might have expressed through advance directives, and/or the wishes of a trusted person or, lastly, of the family. Before making any decision, physicians should respect a collegial medical procedure. Euthanasia defined as the act of terminating one's life on a patient's explicit request remains illegal.
- 1 January 2009
- Published by Springer Nature in Critical Care
- Vol. 13 (1) , 204
Open AccessEthics review: End of life legislation – the French model
French law 2005-370 of April 22, 2005 (Leonetti's law) brings new rights to patients and clarifies medical practices regarding end of life care. This new law prohibits unreasonable obstinacy in investigations or therapeutics and authorizes the withholding or withdrawal of treatments when they appear "useless, disproportionate or having no other effect than solely the artificial preservation of life". Relief from pain is a fundamental right of patients. With regard to pain control, the law also allows doctors to dispense to patients "in an advanced or final phase of a serious and incurable affliction" anti-pain treatments as needed, even if these treatments, as a side effect, hasten their death. The drafting of advance directives regarding end of life constitutes a new right of patients. The decision to withdraw or withhold a treatment from a patient unable to express their will has to take into account the wishes they might have expressed through advance directives, and/or the wishes of a trusted person or, lastly, of the family. Before making any decision, physicians should respect a collegial medical procedure. Euthanasia defined as the act of terminating one's life on a patient's explicit request remains illegal.
- 31 January 2008
- Vol. 58 (2) , 197-200
[Reason and decision-making in medicine. The therapeutic risk].
- 31 January 2008
- Vol. 58 (2) , 197-200
[Reason and decision-making in medicine. The therapeutic risk].
- 30 July 2007
- Published by BMJ in Journal of Medical Ethics
- Vol. 33 (8) , 491-495
Teaching ethics in Europe
Aim:To carry out an appropriate overview and inventory of the teaching of ethics within the European Union Schools of Medicine.Methods:A questionnaire was sent by email to 45 randomly selected medical schools from each of 23 countries in the European Union in February 2006.Results:25 schools of medicine from 18 European countries were included (response rate = 56%). In 21 of 25 medical schools, there was at least one ethics module. In 11 of 25 medical schools, the teaching of ethics was transversal. Only one of the responding schools did not teach ethics. The mean time invested in ethics teaching was 44 h during the overall curriculum.Conclusions:Ethics now has an established place within the medical curriculum throughout the European Union. However, there is a notable disparity in programme characteristics among schools of medicine.
- 30 July 2007
- Published by BMJ in Journal of Medical Ethics
- Vol. 33 (8) , 491-495
Teaching ethics in Europe
Aim:To carry out an appropriate overview and inventory of the teaching of ethics within the European Union Schools of Medicine.Methods:A questionnaire was sent by email to 45 randomly selected medical schools from each of 23 countries in the European Union in February 2006.Results:25 schools of medicine from 18 European countries were included (response rate = 56%). In 21 of 25 medical schools, there was at least one ethics module. In 11 of 25 medical schools, the teaching of ethics was transversal. Only one of the responding schools did not teach ethics. The mean time invested in ethics teaching was 44 h during the overall curriculum.Conclusions:Ethics now has an established place within the medical curriculum throughout the European Union. However, there is a notable disparity in programme characteristics among schools of medicine.
- 1 March 2006
- Published by CAIRN.INFO in Santé Publique
- Vol. 18 (1) , 85-90
Enseignement de l'éthique et des Droits de l'Homme en Europe
Résumé En 1999, l’Association Médicale Mondiale recommandait l’introduction de l’enseignement de l’éthique et des Droits de l’Homme dans le cursus de base des facultés de médecine. La présente étude a pour objectif de faire un état des lieux de cet enseignement dans les facultés de médecine de l’Union européenne. Une enquête par questionnaire auto-administré a été menée en 2002 auprès de 219 facultés de médecine, de 14 des 15 États membres de l’Union européenne, le Luxembourg n’avait pas encore de faculté de médecine. Un quart des facultés ont répondu. L’enseignement de l’éthique est présent dans 93 % des établissements, il est multidisciplinaire dans 80 % des cas et obligatoire dans 75 % des cas. L’enseignement des Droits de l’Homme est présent dans 63 % des établissements, il est le plus souvent incorporé dans l’enseignement de l’éthique. Si l’objectif de l’AMM n’est pas toujours atteint, cette étude montre néanmoins une prise de conscience de l’importance d’un tel enseignement dans les facultés de médecines européennes.
- 1 March 2006
- Published by CAIRN.INFO in Santé Publique
- Vol. 18 (1) , 85-90
Enseignement de l'éthique et des Droits de l'Homme en Europe
Résumé En 1999, l’Association Médicale Mondiale recommandait l’introduction de l’enseignement de l’éthique et des Droits de l’Homme dans le cursus de base des facultés de médecine. La présente étude a pour objectif de faire un état des lieux de cet enseignement dans les facultés de médecine de l’Union européenne. Une enquête par questionnaire auto-administré a été menée en 2002 auprès de 219 facultés de médecine, de 14 des 15 États membres de l’Union européenne, le Luxembourg n’avait pas encore de faculté de médecine. Un quart des facultés ont répondu. L’enseignement de l’éthique est présent dans 93 % des établissements, il est multidisciplinaire dans 80 % des cas et obligatoire dans 75 % des cas. L’enseignement des Droits de l’Homme est présent dans 63 % des établissements, il est le plus souvent incorporé dans l’enseignement de l’éthique. Si l’objectif de l’AMM n’est pas toujours atteint, cette étude montre néanmoins une prise de conscience de l’importance d’un tel enseignement dans les facultés de médecines européennes.
- 1 February 2004
- Vol. 91 (2) , 201-3
[The center of biological ressources for the lung cancer].